Pillai, S
Duvvuru, S
Bhatnagar, P
Foster, W
Farmen, M
Shankar, S
Harris, C
Bastyr, E III
Hoogwerf, B
Haupt, A
Article History
Received: 30 March 2017
Revised: 24 July 2017
Accepted: 4 August 2017
First Online: 21 November 2017
Competing interests
: The authors declare no conflict of interest. SP, SD, PB, WF, MF, SS, CH, BH and AH are employees and shareholders of Eli Lilly and Company. EB was an employee of Eli Lilly and Company during the trial and is currently a consultant to Viacyte, San Diego, CA, USA.